FDA committee recommends six new Peptides for “Pharmacy Compounding List”

[Saleem Ahmad]

Six new peptides have been greenlit for inclusion in the US Food and Drug Administration’s 503A Bulks List.

The move, by the agency’s pharmacy compounding advisory committee, means that licenced pharmacies will be allowed to combine or alter drug ingredients to make “compounded” versions of these molecules for individual patients.

Peptides recommended by FDA pharmacy compounding advisory committee

BPC-157

KPV

TB-500

MOTs-C

Epitalon

Semax

• This Question was modified 1 month ago by Saleem Ahmad.

[Author]

Posts